These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High-throughput screening tools facilitate calculation of a combined exposure-bioactivity index for chemicals with endocrine activity. Wegner SH; Pinto CL; Ring CL; Wambaugh JF Environ Int; 2020 Apr; 137():105470. PubMed ID: 32050122 [TBL] [Abstract][Full Text] [Related]
5. High-throughput screening and chemotype-enrichment analysis of ToxCast phase II chemicals evaluated for human sodium-iodide symporter (NIS) inhibition. Wang J; Hallinger DR; Murr AS; Buckalew AR; Lougee RR; Richard AM; Laws SC; Stoker TE Environ Int; 2019 May; 126():377-386. PubMed ID: 30826616 [TBL] [Abstract][Full Text] [Related]
6. Towards replacement of animal tests with in vitro assays: a gene expression biomarker predicts in vitro and in vivo estrogen receptor activity. Corton JC; Liu J; Kleinstreuer N; Gwinn MR; Ryan N Chem Biol Interact; 2022 Aug; 363():109995. PubMed ID: 35697134 [TBL] [Abstract][Full Text] [Related]
7. Exploring the effects of experimental parameters and data modeling approaches on in vitro transcriptomic point-of-departure estimates. Harrill JA; Everett LJ; Haggard DE; Bundy JL; Willis CM; Shah I; Friedman KP; Basili D; Middleton A; Judson RS Toxicology; 2024 Jan; 501():153694. PubMed ID: 38043774 [TBL] [Abstract][Full Text] [Related]
8. Application of Cell Painting for chemical hazard evaluation in support of screening-level chemical assessments. Nyffeler J; Willis C; Harris FR; Foster MJ; Chambers B; Culbreth M; Brockway RE; Davidson-Fritz S; Dawson D; Shah I; Friedman KP; Chang D; Everett LJ; Wambaugh JF; Patlewicz G; Harrill JA Toxicol Appl Pharmacol; 2023 Jun; 468():116513. PubMed ID: 37044265 [TBL] [Abstract][Full Text] [Related]
9. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model. Browne P; Judson RS; Casey WM; Kleinstreuer NC; Thomas RS Environ Sci Technol; 2015 Jul; 49(14):8804-14. PubMed ID: 26066997 [TBL] [Abstract][Full Text] [Related]
10. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models. Nelms MD; Antonijevic T; Ring C; Harris DL; Bever RJ; Lynn SG; Williams D; Chappell G; Boyles R; Borghoff S; Edwards SW; Markey K Front Toxicol; 2024; 6():1346767. PubMed ID: 38694816 [TBL] [Abstract][Full Text] [Related]
11. A 50-gene biomarker identifies estrogen receptor-modulating chemicals in a microarray compendium. Corton JC; Matteo G; Chorley B; Liu J; Vallanat B; Everett L; Atlas E; Meier MJ; Williams A; Yauk CL Chem Biol Interact; 2024 May; 394():110952. PubMed ID: 38570061 [TBL] [Abstract][Full Text] [Related]
12. Expanded high-throughput screening and chemotype-enrichment analysis of the phase II: e1k ToxCast library for human sodium-iodide symporter (NIS) inhibition. Wang J; Richard AM; Murr AS; Buckalew AR; Lougee RR; Shobair M; Hallinger DR; Laws SC; Stoker TE Arch Toxicol; 2021 May; 95(5):1723-1737. PubMed ID: 33656581 [TBL] [Abstract][Full Text] [Related]
13. Combining phenotypic profiling and targeted RNA-Seq reveals linkages between transcriptional perturbations and chemical effects on cell morphology: Retinoic acid as an example. Nyffeler J; Willis C; Harris FR; Taylor LW; Judson R; Everett LJ; Harrill JA Toxicol Appl Pharmacol; 2022 Jun; 444():116032. PubMed ID: 35483669 [TBL] [Abstract][Full Text] [Related]
14. Identification of Androgen Receptor Modulators in a Prostate Cancer Cell Line Microarray Compendium. Rooney JP; Chorley B; Kleinstreuer N; Corton JC Toxicol Sci; 2018 Nov; 166(1):146-162. PubMed ID: 30085300 [TBL] [Abstract][Full Text] [Related]
15. Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor. Judson RS; Magpantay FM; Chickarmane V; Haskell C; Tania N; Taylor J; Xia M; Huang R; Rotroff DM; Filer DL; Houck KA; Martin MT; Sipes N; Richard AM; Mansouri K; Setzer RW; Knudsen TB; Crofton KM; Thomas RS Toxicol Sci; 2015 Nov; 148(1):137-54. PubMed ID: 26272952 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space. Shah F; Greene N Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225 [TBL] [Abstract][Full Text] [Related]
17. Potential of ToxCast Data in the Safety Assessment of Food Chemicals. Punt A; Firman J; Boobis A; Cronin M; Gosling JP; Wilks MF; Hepburn PA; Thiel A; Fussell KC Toxicol Sci; 2020 Apr; 174(2):326-340. PubMed ID: 32040188 [TBL] [Abstract][Full Text] [Related]
18. Considerations for Strategic Use of High-Throughput Transcriptomics Chemical Screening Data in Regulatory Decisions. Harrill J; Shah I; Setzer RW; Haggard D; Auerbach S; Judson R; Thomas RS Curr Opin Toxicol; 2019; 15():64-75. PubMed ID: 31501805 [TBL] [Abstract][Full Text] [Related]